Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 119
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.
| Dosage form | NDCs |
|---|---|
| capsule | 4 |
| Route | NDCs |
|---|---|
| oral | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| amarin pharma inc. | 4 |
Exclusivity
Patents and exclusivities
119| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9700537 | VASCEPAicosapent ethyl | use | May 2027 |
| 9198892 | VASCEPAicosapent ethyl | use | Sept 2027 |
| 12171738 | VASCEPAicosapent ethyl | use | Feb 2030 |
| 8399446 | VASCEPAicosapent ethyl | use | Feb 2030 |
| 8415335 | VASCEPAicosapent ethyl | use | Feb 2030 |
| 8426399 | VASCEPAicosapent ethyl | use | Feb 2030 |
| 8518929 | VASCEPAicosapent ethyl | use | Feb 2030 |
| 8524698 | VASCEPAicosapent ethyl | use | Feb 2030 |
| 8546372 | VASCEPAicosapent ethyl | use | Feb 2030 |
| 8680144 | VASCEPAicosapent ethyl | use | Feb 2030 |
| 10010517 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 10265287 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 10792267 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 10842766 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 10881632 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 11103477 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 11154526 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 11213504 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 11717504 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8298554 | VASCEPAicosapent ethyl | product | Apr 2030 |
| 8445003 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8445013 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8454994 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8501225 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8563608 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8617593 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8617594 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8618166 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8623406 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8642077 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8691871 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8703185 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 8709475 | VASCEPAicosapent ethyl | use | Apr 2030 |
| 10842768 | VASCEPAicosapent ethyl | use | Jun 2030 |
| 8410086 | VASCEPAicosapent ethyl | use | Jun 2030 |
| 8455472 | VASCEPAicosapent ethyl | use | Jun 2030 |
| 8669245 | VASCEPAicosapent ethyl | use | Jun 2030 |
| 8710041 | VASCEPAicosapent ethyl | use | Jun 2030 |
| 10278935 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10278936 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10278937 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10383840 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10555924 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10555925 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10568861 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10576054 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10668042 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10786478 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10792270 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 10894028 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 11000499 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 11116742 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 11298333 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 11369582 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 9603826 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 9610272 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 9623001 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 9693984 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 9693985 | VASCEPAicosapent ethyl | use | Jun 2033 |
| 9693986 | VASCEPAicosapent ethyl | use | Jun 2033 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Vascepa | icosapent ethyl | capsule, oral | 52937-001NDA |
| Vascepa | icosapent ethyl | capsule, oral | 52937-003NDA |
| Vascepa | icosapent ethyl | capsule, oral | 52937-005NDA |
| Vascepa | icosapent ethyl | capsule, oral | 52937-101NDA |
Compare
Other companies listing icosapent ethyl
- Epic Laboratories, LLC3 sites · 209 NDC
- SOFTGEL HEALTHCARE PRIVATE LIMITED2 sites · 38 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
- NEXTPHARMA PLOERMEL1 site · 2 NDC
- Patheon Softgels, Inc.0 sites · 139 NDC
Enquiry
Common questions
- Is Amarin Pharma Inc. FDA approved?
- Amarin Pharma Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Amarin Pharma Inc. make?
- 4 products are listed under Amarin Pharma Inc. in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.